Phlow Email Format
Pharmaceutical ManufacturingVirginia, United States51-200 Employees
Phlow is a United States-based pharmaceutical contract development and manufacturing organization (CDMO) headquartered at 424 Hull Street Suite 400, Richmond, Virginia 23224, and it employs 51-200 people. It operates in the pharmaceutical manufacturing sector and is structured as a B Corporation, offering advanced development and manufacturing services for drug substances to government and private industry customers in America. The company highlights scientific expertise, world-class manufacturing, and technology-enabled processes to increase speed to market, reduce waste, and promote environmentally friendly manufacturing practices. In 2025 and 2026, Phlow announced leadership changes, including the appointment of Tim Mayleben as CEO in May 2026 and Dawn Von Rohr as COO in March 2026, with co-founder Dr. Eric Edwards moving to Chairman Emeritus and Strategic Advisor. Phlow has engaged in partnerships and funding activity, including a January 2026 collaboration with Enveda Therapeutics on AI-driven API manufacturing, and a Series C funding round reported in August 2025.